Old Web
English
Sign In
Acemap
>
authorDetail
>
Suhendan Ekmekcioglu
Suhendan Ekmekcioglu
Beth Israel Deaconess Medical Center
Immunology
Dose Reduced
In vivo
Population
Cytokine
2
Papers
7
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Dual inhibition of VEGF pathway: Phase I trial of bevacizumab and cediranib in advanced solid tumors.
2011
Journal of Clinical Oncology
Ignacio Garrido–Laguna
R. Kurzrock
Jennifer J. Wheler
G. S. Falchook
Sarina Anne Piha-Paul
Siqing Fu
Aung Naing
C Hinojosa
Reena Mistry
A. Scamardo
Kirk S. Culotta
Suhendan Ekmekcioglu
Sijin Wen
Luis H. Camacho
S. P. Ivy
David Sanghyun Hong
Show All
Source
Cite
Save
Citations (2)
Phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies
2007
Molecular Cancer Therapeutics
David Hong
Razelle Kurzrock
Jeffrey Supko
Donald Lawrence
Jennifer Wheeler
Joseph P. Eder
Chaan Ng
James W. Mier
Marina Konopleva
Sergej Konoplev
Suhendan Ekmekcioglu
Michael Andreeff
Elizabeth A. Grimm
Donald W Kufe
Colin Meyer
Geoffrey Shapiro
Bruce J. Dezube
Show All
Source
Cite
Save
Citations (5)
1